Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS)
Publication
, Conference
Syed, YA; Jiang, C; Switchenko, J; Kirmani, K; Kelsey, CR; Khan, MK
Published in: International Journal of Radiation Oncology*Biology*Physics
September 2019
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2019
Volume
105
Issue
1
Start / End Page
S249 / S249
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Syed, Y. A., Jiang, C., Switchenko, J., Kirmani, K., Kelsey, C. R., & Khan, M. K. (2019). Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS). In International Journal of Radiation Oncology*Biology*Physics (Vol. 105, pp. S249–S249). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2019.06.370
Syed, Y. A., C. Jiang, J. Switchenko, K. Kirmani, C. R. Kelsey, and M. K. Khan. “Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS).” In International Journal of Radiation Oncology*Biology*Physics, 105:S249–S249. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.370.
Syed YA, Jiang C, Switchenko J, Kirmani K, Kelsey CR, Khan MK. Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS). In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019. p. S249–S249.
Syed, Y. A., et al. “Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS).” International Journal of Radiation Oncology*Biology*Physics, vol. 105, no. 1, Elsevier BV, 2019, pp. S249–S249. Crossref, doi:10.1016/j.ijrobp.2019.06.370.
Syed YA, Jiang C, Switchenko J, Kirmani K, Kelsey CR, Khan MK. Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS). International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019. p. S249–S249.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2019
Volume
105
Issue
1
Start / End Page
S249 / S249
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences